These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Intravenous administration of adenosine triphosphate and phosphocreatine combined with fluoxetine in major depressive disorder: protocol for a randomized, double-blind, placebo-controlled pilot study. Chen Y; Cao X; Zang W; Tan S; Ou CQ; Shen X; Gao T; Zhao L Trials; 2019 Jan; 20(1):34. PubMed ID: 30626424 [TBL] [Abstract][Full Text] [Related]
6. Adverse events and treatment discontinuations in clinical trials of fluoxetine in major depressive disorder: an updated meta-analysis. Beasley CM; Koke SC; Nilsson ME; Gonzales JS Clin Ther; 2000 Nov; 22(11):1319-30. PubMed ID: 11117656 [TBL] [Abstract][Full Text] [Related]
7. Delirium Associated With Fluoxetine Discontinuation: A Case Report. Fan KY; Liu HC Clin Neuropharmacol; 2017; 40(3):152-153. PubMed ID: 28452902 [TBL] [Abstract][Full Text] [Related]
8. Switching patients from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine in the maintenance of response for depression. Miner CM; Brown EB; Gonzales JS; Munir R J Clin Psychiatry; 2002 Mar; 63(3):232-40. PubMed ID: 11926723 [TBL] [Abstract][Full Text] [Related]
13. The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases. Keller MB; Trivedi MH; Thase ME; Shelton RC; Kornstein SG; Nemeroff CB; Friedman ES; Gelenberg AJ; Kocsis JH; Dunner DL; Hirschfeld RM; Rothschild AJ; Ferguson JM; Schatzberg AF; Zajecka JM; Pedersen RD; Yan B; Ahmed S; Musgnung J; Ninan PT J Clin Psychiatry; 2007 Aug; 68(8):1246-56. PubMed ID: 17854250 [TBL] [Abstract][Full Text] [Related]
14. Fluoxetine treatment for prevention of relapse of depression in children and adolescents: a double-blind, placebo-controlled study. Emslie GJ; Heiligenstein JH; Hoog SL; Wagner KD; Findling RL; McCracken JT; Nilsson ME; Jacobson JG J Am Acad Child Adolesc Psychiatry; 2004 Nov; 43(11):1397-405. PubMed ID: 15502599 [TBL] [Abstract][Full Text] [Related]
15. Discontinuation syndrome in dysthymic patients treated with selective serotonin reuptake inhibitors: a clinical investigation. Bogetto F; Bellino S; Revello RB; Patria L CNS Drugs; 2002; 16(4):273-83. PubMed ID: 11945110 [TBL] [Abstract][Full Text] [Related]
16. Fluoxetine: new indication. Depression in children: too many uncertainties. Prescrire Int; 2008 Oct; 17(97):186-7. PubMed ID: 19534039 [No Abstract] [Full Text] [Related]
17. Venlafaxine extended-release: a review of its use in the management of major depression. Wellington K; Perry CM CNS Drugs; 2001; 15(8):643-69. PubMed ID: 11524036 [TBL] [Abstract][Full Text] [Related]